Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Qiagen N.V.

Qiagen N.V. (QGEN) Stock Overview

Explore Qiagen N.V.’s financial performance, market position, analyst ratings, and future outlook.

QGEN●NYSE
HealthcareMedical - Diagnostics & Research
$41.35
$0.21(0.49%)
U.S. Market is Open · 15:23

Qiagen N.V. (QGEN)

Meyka AI Score

Z

Key Financials

Market Cap8.5B
P/E Ratio22.01
EPS (TTM)$2.40
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$41.94
3 Months$33.33
1 Year Target$45.37

QGEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Qiagen N.V. (QGEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.58, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $45.37.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 22.01 and a market capitalization of 8.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.41%
5-Day Change
-1.03%
1-Month Change
11.83%
3-Month Change
-0.60%
6-Month Change
-14.45%
Year-to-Date (YTD) Change
-12.57%
1-Year Change
-12.77%
3-Year Change
-10.20%
5-Year Change
-14.25%
All-Time (Max) Change
1990.40%

Contact Information

https://www.qiagen.com
31 77 355 6600
Hulsterweg 82, Venlo, LI, 5912 PL

Company Facts

57,360 Employees
IPO DateJun 28, 1996
CountryNL
Actively Trading

Frequently Asked Questions